Commercial Egg-laying Hens Research Articles

Effects of F-strain Mycoplasma gallisepticum inoculation on serum very low density lipoprotein diameter and fractionation of cholesterol among lipoproteins in commercial egg-laying hens

Experimental inoculation with the F-strain of Mycoplasma gallisepticum (FMG) at 12 wk of age has been shown to affect the performance, liver, reproductive organs, and yolk lipid characteristics of commercial layers. Therefore, this study was conducted to determine the serum lipoprotein characteristics of commercial egg-laying hens at 16 wk of age and throughout lay after inoculation with FMG at 12 wk of age. Mean diameters of very low density lipoproteins (VLDL) were determined for the 10th, 50th, and 90th percentiles of serum total VLDL of each hen. Percentages of total serum cholesterol recovered in VLDL and low and high density lipoprotein particle classes were also determined. Inoculation of birds with FMG at 12 wk did not change the physical properties or relative concentrations of their circulating lipoproteins. However, the age of the bird had significant differential effects on all the parameters examined. These data demonstrate that FMG-inoculation at 12 wk of age does not affect the lipoproteins of laying hens, but because these birds were housed in biological isolation units, these results do not preclude the possibility that these yolk precursors may be affected in FMG-infected birds that are housed in facilities in which there are increased levels of environmental stress. These data further suggest that alterations in liver, reproductive organs, and yolk lipid characteristics in response to FMG, as noted in previous reports on commercial layers, are not mediated through changes in circulating VLDL diameters.

Influences of supplemental dietary poultry fat and F-strain Mycoplasma gallisepticum infection on the early performance of commercial egg laying hens

F-strain Mycoplasma gallisepticum (FMG) may alter reproductive performance in layers through its effects on lipid metabolism. Therefore, the influences of 1.5% supplemental dietary poultry fat (PF) and FMG infection on the early performance of commercial egg-laying hens were determined. Birds were either sham- or FMG-inoculated at 12 wk, and experimental diets were initiated at 20 wk of age. Body weight at 12, 20, and 24 wk, total daily egg mass, feed consumption and feed conversion at 20 and 24 wk, weekly egg weight between 19 and 26 wk, weekly egg production (EP) between 18 and 26 wk, and weekly mortality between 12 and 26 wk of age were determined. Inoculation with FMG reduced EP at 18 and 19 wk of age. Between 20 and 26 wk, FMG reduced EP in birds fed control diets, conversely, PF eliminated differences in EP between sham- and FMG-inoculated birds. Furthermore, at wk 20 and 24, birds consumed less feed when fed PF-supplemented diets than when fed control diets if they were sham-inoculated, but the difference in feed consumption between diets was ameliorated if birds were previously inoculated with FMG. These data demonstrate that the effects of a 12-wk inoculation of FMG on EP and feed consumption through 26 wk of age in commercial egg-laying chickens can be modified by 1.5% supplemental dietary P F. More specifically, PF may alleviate reductions in early EP due to FMG.

Effects of F-strain Mycoplasma gallisepticum inoculation at twelve weeks of age on performance and egg characteristics of commercial egg-laying hens

The effects of F-strain Mycoplasma gallisepticum (FMG) inoculation during the pullet period on the subsequent performance and egg characteristics of commercial Single Combed White Leghorn hens were evaluated. In two trials, BW, feed consumption, egg production (EP), egg weight, egg size class, relative eggshell water vapor conductance, and relative percentages of eggshell, yolk and albumen weights were determined through approximately 60 wk of age. In each trial, pullets at 12 wk of age were randomly assigned to negative pressure biological isolation units. Birds in one-half of the total units were inoculated with FMG, and the other half were sham-inoculated with sterile media. In both trials, onset of lay was delayed approximately 1 wk in layers inoculated with FMG. Control birds that had not been previously inoculated with FMG laid their first egg at 18 wk of age, while birds that had been previously inoculated with FMG laid their first egg at 19 wk of age. In Trial 1, FMG-inoculated hens laid significantly fewer total eggs, which became apparent at each week after Week 42. In Trial 2, a numerical decrease in total EP occurred, and the percentage of undersized eggs laid by FMG-inoculated birds was significantly lower at 19 wk of age but was higher at 20 and 21 wk when compared to controls. Mortality was not significantly different between the treatments in either trial. These data demonstrate that when birds are housed in isolation facilities and inoculated with FMG at 12 wk of age, onset of lay is delayed. These data also suggest that FMG may lead to delays in undersize EP and decreases in total EP. However, because significant FMG effects on these parameters were observed in only one trial, additional studies may be necessary to verify these effects.